Skip to main content
IMS Events Main banner

    Ajai Chari, MD

    Director of Multiple Myeloma Program Professor of Clinical Medicine
    University of California, San Francisco
    San Francisco, California

    Dr. Chari has published extensively on plasma cell disorders and has been invited to speak regionally, nationally, and internationally. His research interests include the development of novel chemotherapy regimens, including phase 1 and 2 studies. He is principal investigator (PI) of several investigator-initiated trials as well as the national and international PI of studies. As the Director of Clinical Research in the Multiple Myeloma Program, he oversees a program renowned nationally not only for high volume patient accruals but also rigorous quality assurance. The program has played a pivotal role in the approval of nearly all of the most recent drugs to be approved by the FDA for the treatment of multiple myeloma.

    Disclosure information not submitted.

    Presentation(s):